One-Year EVOLVE Trial Clinical Results Confirm Comparable Safety And Effectiveness Data Of The Boston Scientific SYNERGY Stent Versus PROMUS Element Platinum Chromium Stent

Source :: Biotech Week. May 30, 2012, 1130
Publication Year :: 2012
Abstract: By a News Reporter-Staff News Editor at Biotech Week -- Boston Scientific Corporation (NYSE: BSX) announces that the SYNERGY™ Everolimus-Eluting Bioabsorbable Polymer-Coated Platinum Chromium Coronary Stent System demonstrated non-inferior results [...]

Subjects :: Boston Scientific Corp. -- Product development
Stent (Surgery) -- Product development
Medical test kit industry -- Product development
Biotechnology industry -- Product development
Medical equipment and supplies industry -- Product development
Biotechnology industry
Pharmaceuticals and cosmetics industries

Tools